ctrl K

Price Alert

Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

4.71

-0.08 (-1.67%)

At close: Aug 15, 2025, 3:59 PM

4.72

0.21%

After-hours: Aug 15, 2025, 05:36 PM EDT

Lexeo Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	35.01M	121.47M	77.33M	135.86M
Short-Term Investments	86.5M	n/a	n/a	n/a
Long-Term Investments	7.01M	n/a	n/a	n/a
Other Long-Term Assets	3.25M	3.25M	7.49M	2K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.6M	3K	371K	696K
Total Current Assets	126.12M	124.29M	80.05M	136.68M
Property-Plant & Equipment	10.56M	12.26M	13.78M	174K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.82M	15.51M	21.26M	176K
Total Assets	146.94M	139.81M	97.08M	136.86M
Account Payables	6.42M	3.79M	2.68M	3.06M
Deferred Revenue	n/a	n/a	n/a	46K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	4.66M	3.36M	2.15M	961K
Total Current Liabilities	22.85M	17.24M	14.35M	7.45M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	185.03M	185.01M
Total Long-Term Liabilities	7.25M	9.03M	195.68M	185.01M
Total Liabilities	30.1M	26.27M	210.03M	192.46M
Total Debt	9.92M	11.64M	13.48M	n/a
Common Stock	3K	3K	n/a	1.68K
Retained Earnings	-280.17M	-181.84M	-115.45M	-56.17M
Comprehensive Income	-103K	n/a	-185.03M	-185.01M
Shareholders Equity	116.84M	113.53M	-112.95M	-55.6M
Total Investments	93.52M	3.25M	3.25M	n/a